Eli Lilly to launch diabetes, obesity drug in India next year

Sunday, 8 December 2024

0 shares	Share Tweet Save Post Send

Weight loss drug gets US nod to treat sleep apnea; India launch likely next year

The US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the...
IndiaTimes on December 24, 2024

Eli Lilly to launch diabetes, obesity drug in India next year

You Might Like

Related news from verified sources

Weight loss drug gets US nod to treat sleep apnea; India launch likely next year